Cargando…
Conventional and biologic disease-modifying anti-rheumatic drugs for osteoarthritis: a meta-analysis of randomized controlled trials
OBJECTIVES: The role of inflammation in OA is controversial and it is unclear whether suppressing inflammation with conventional or biologic DMARDs is effective. A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to compare DMARDs with placebo in participants...
Autores principales: | Persson, Monica S M, Sarmanova, Aliya, Doherty, Michael, Zhang, Weiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199417/ https://www.ncbi.nlm.nih.gov/pubmed/29917100 http://dx.doi.org/10.1093/rheumatology/key131 |
Ejemplares similares
-
Predicting response to topical non-steroidal anti-inflammatory drugs in osteoarthritis: an individual patient data meta-analysis of randomized controlled trials
por: Persson, Monica S M, et al.
Publicado: (2020) -
A meta-analysis of randomized controlled trials investigating tirofiban combined with conventional drugs by intracoronary administration for no-reflow prevention
por: Zeng, Qian, et al.
Publicado: (2020) -
Reliability of detection of ultrasound and MRI features of hand osteoarthritis: a systematic review and meta-analysis
por: Obotiba, Abasiama D, et al.
Publicado: (2021) -
Risk of infections of biological and targeted drugs in patients with spondyloarthritis: meta-analysis of randomized clinical trials
por: Hu, Lidong, et al.
Publicado: (2022) -
Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis
por: Weng, Chenghua, et al.
Publicado: (2021)